Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke
Status:
Terminated
Trial end date:
2020-10-19
Target enrollment:
Participant gender:
Summary
This study will assess the potential efficacy and safety of TSC as early treatment for both
ischemic and hemorrhagic stroke when administered while subject is in ambulance being
transported to hospital.
Phase:
Phase 2
Details
Lead Sponsor:
Diffusion Pharmaceuticals Inc
Collaborators:
University of California, Los Angeles University of Virginia